Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology
Puma Biotechnology
Puma Biotech's Breast Cancer Drug Results Mint New Billionaire Overnight
Alan H. Auerbach - Founder, Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Puma Biotechnology Surging
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Dennis Sanders - Senior Clinical Specialist - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
PharmaShots - Incisive news in 3 shots on Twitter: "Puma Biotechnology Reports Results of Neratinib (PB272) in P-III NALA Trial for 3L HER2-Positive Metastatic Breast Cancer https://t.co/KKTvnp68jJ https://t.co/LR02TGd4oT" / Twitter
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology
Articles about Puma Biotechnology | page 6
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Exhibitor Puma Biotechnology 07-10 - Scripps CME Connection
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
